Study shows drug remdesivir lowers death risk for COVID-19 patients by 62%

By Gotham Rex on July 10, 2020

The antiviral drug remdesivir reduces the risk of death for severely ill coronavirus patients by 62 percent, the company that makes it said Friday. Gilead Sciences said the use of the medication was linked to “significantly improved clinical recovery” in a study of hundreds of clinical trial patients, which will be presented to scientists at…
Source: NY Post click here for more…